natgillin/translations-raw huggingface dataset:
Warning sentences and advice for safe use have been included in the product information, which reflect the lack of target animal safety data in horses and foals.
V informacije o zdravilu so bili vključeni opozorilni stavki in nasveti za varno uporabo, ki opozarjajo na pomanjkljive podatke o varnosti za ciljno živalsko vrsto, ki so na voljo za konje in žrebeta.
The genes encoding for aminoglycoside modifying enzymes are usually found on plasmids and transposons.
Geni, ki kodirajo encime, ki spremenijo aminoglikozide, so običajno prisotni na plazmidih in transpozonih.
• on the basis of the available data, the CVMP considered that the indication as provided in Annex III
• odbor CVMP je na podlagi razpoložljivih podatkov menil, da je indikacija, kot je navedena v
Gentamicin does not distribute to the cerebrospinal fluid.
Gentamicin se ne porazdeli v cerebrospinalno tekočino.
It was understood that the indications would not be unique to these two products and other injectable veterinary medicinal products containing gentamicin for use in horses authorised in the EU have approved different doses, and the concers and considerations would apply equally to these.
Ugotovljeno je bilo, da indikacije ne bi bile odobrene samo za ti dve zdravili in da so za druga v EU odobrena zdravila za injiciranje za uporabo v veterinarski medicini, ki vsebujejo gentamicin in se uporabljajo pri konjih, odobreni drugačni odmerki, zato se zadržki in pomisleki nanašajo tudi na ta zdravila.
The product should therefore only be used based on the benefit-risk assessment by the responsible veterinary surgeon for each individual horse, taking into account alternative available treatment.
Zdravilo se zato lahko uporablja samo na podlagi ocene razmerja med tveganji in koristmi, ki jo pristojni veterinar poda za vsakega konja posebej, pri čemer mora upoštevati druge razpoložljive možnosti zdravljenja.
Spain Laboratorios e Industrias IVEN, S.A
Španija Laboratorios e Industrias IVEN, S.A
Therapeutic blood monitoring of gentamicin concentration is also recommended because of known individual animal variations in peak and trough gentamicin plasma concentrations.
Prav tako se priporoča terapevtsko spremljanje koncentracije gentamicina v krvi, saj je znano, da se najvišje in najnižje koncentracije gentamicina v plazmi pri posameznih živalih razlikujejo.
Overall summary of the scientific evaluation of veterinary medicinal products containing gentamicin presented as solutions for injection to be administered to horses (see Annex I)
Splošni povzetek znanstvenega vrednotenja zdravil za uporabo v veterinarski medicini, ki vsebujejo gentamicin in so na voljo v obliki raztopin za injiciranje za konje (glejte Prilogo I)
This is primarily due to its fast bacteriocidal effect against Gram-negative bacteria for which there are only limited treatment choices available, its chemical stability and synergy with betalactam antibiotics.
Razlogi za to so predvsem njihovo hitro baktericidno delovanje proti gramnegativnim bakterijam, za katere so na voljo omejene možnosti zdravljenja, njihova kemijska stabilnost in sinergija z betalaktamskimi antibiotiki.
Based on all available evidence, the CVMP considered that a single daily dose of 6.6 mg gentamicin/kg bw, administered intravenously, would provide an efficacious dose, taking into account the desired PK/PD characteristics for a concentration-dependent antibiotic, i.e. optimal maximum serum concentration (Cmax) to MIC ratio of 8-10, and assuming a bacterial MIC ≤2 µg/ml.
Na podlagi vseh razpoložljivih dokazov je odbor CVMP menil, da bi enkratni dnevni odmerek 6,6 mg gentamicina/kg telesne mase, dan intravensko, zagotovil učinkovit odmerek glede na želene farmakokinetične/farmakodinamične lastnosti za antibiotik, odvisen od koncentracije, tj. optimalno razmerje med največjo serumsko koncentracijo (Cmaks) in MIK 8-10, ter ob predpostavki, da je MIK bakterij ≤ 2 µg/ml.
• the CVMP considered that the overall benefit-risk balance is positive for the veterinary medicinal products (see annex I), subject to amendments in the product information; the CVMP recommended variations of the marketing authorisations for veterinary medicinal products containing gentamicin presented as solutions for injection to be administered to horses, in order to amend the summaries of product characteristics, labelling and package leaflets as set out in Annex III.
• odbor CVMP je menil, da je splošno razmerje med tveganji in koristmi za zdravila za uporabo v veterinarski medicini (glejte Prilogo I) pozitivno, če se upoštevajo spremembe v informacijah o zdravilu; je odbor CVMP priporočil spremembo dovoljenj za promet z zdravilom za zdravila za uporabo v veterinarski medicini, ki vsebujejo gentamicin in so na voljo v obliki raztopin za injiciranje za konje, tako da bodo v povzetke glavnih značilnosti zdravila, označevanje in navodila za uporabo uvedene spremembe, navedene v Prilogi III.
Latvia KELA N.V. St. Lenaartseweg 48 2320 Hoogstraten Belgium
St. Lenaartseweg 48 2320 Hoogstraten Belgija
Gentamicin does not have effects on anaerobe bacteria and mycoplasmas.
Gentamicin nima učinka na anaerobne bakterije in mikoplazme.
Studies on the margin of safety of the currently approved dosing regimens were neither submitted by the MAHs nor could be identified in the scientific literature.
Imetniki dovoljenj za promet z zdravilom niso predložili študij o terapevtskem indeksu pri trenutno odobrenih režimih odmerjanja, prav tako pa jih ni bilo mogoče zaslediti v znanstveni literaturi.
Differences between neonatal foal kidneys and adults include a slower clearance of gentamicin in foals.
Ena od razlik med ledvicami novorojenih žrebet in odraslih konjev je tudi počasnejše izločanje gentamicina pri žrebetih.
In addition, gentamicin is known to be one of the most nephrotoxic aminoglycosides, with a very narrow margin of safety, which is of particular concern in young aninmals, i.e. foals.
Poleg tega je znano, da je gentamicin eden od najbolj nefrotoksičnih aminoglikozidov z zelo ozkim terapevtskim indeksom, kar je še posebej zaskrbljujoče pri mladih živalih, tj. žrebetih.
Gentamicin is best considered as a narrow-spectrum Gram-negative bactericidal antimicrobial (e.g. E. coli, Proteus, Pseudomonas).
Gentamicin je najbolje obravnavati kot antibiotik ozkega spektra z baktericidnim delovanjem proti gramnegativnim bakterijam (npr. E. coli, Proteus, Pseudomonas).
An application for the product Genta Equine 10% solution for injection for horses, containing gentamicin as the active substance was submitted to Denmark as a concerned Member State in a mutual recognition procedure (MRP) under the legal basis of Article 13(1) of Directive 2001/82/EC, i.e. a generic application.
Danski kot zadevni državi članici v postopku z medsebojnim priznavanjem je bila predložena vloga za zdravilo Genta Equine 10-odstotna raztopina za injiciranje za konje, ki vsebuje zdravilno učinkovino gentamicin, na pravni podlagi člena 13(1) Direktive 2001/82/ES, kar pomeni, da je šlo za generično vlogo.
Currently injectable veterinary medicinal products containing gentamicin for use in horses are authorised in the EU for the treatment of a variety of indications, including broad ones such as infections of the respiratory tract, gastrointestinal, and genito-urinary tract, caused by various target pathogens.
Trenutno razpoložljiva zdravila za injiciranje za uporabo v veterinarski medicini, ki vsebujejo gentamicin in se uporabljajo pri konjih, so v EU odobrena za zdravljenje različnih indikacij, med katerimi so tudi široke indikacije, kot so okužbe dihal, prebavil ter sečil in spolovil, ki jih povzročajo različni ciljni patogeni.
Their rate of killing increases as the gentamicin concentration increases above the minimum concentration (MIC) for a given Gram-negative pathogen, with optimal maximum serum concentration (Cmax) to MIC ratio of 8
Hitrost uničevanja bakterij se poveča, ko je koncentracija gentamicina večja od minimalne koncentracije (MIK) za določene gramnegativne patogene, pri čemer je optimalno razmerje med najvišjo serumsko koncentracijo (Cmaks) in MIK 8-10.
The lack of data and limited scientific evidence would only support a narrow indication, i.e. “For the treatment of infections of the lower respiratory tract in horses caused by aerobic Gram-negative bacteria susceptible to gentamicin.” This indication is consistent with the distribution pattern of gentamicin, which is primarily in the extracellular fluid.
Pomanjkljivi podatki in omejeni znanstveni dokazi podpirajo samo ozko indikacijo, in sicer: „Za zdravljenje okužb spodnjih dihal pri konjih, ki jih povzročajo aerobne gramnegativne bakterije, občutljive za gentamicin.“ Ta indikacija je skladna z vzorcem porazdelitve gentamicina, ki se v glavnem porazdeli v zunajcelično tekočino.
Pharmacotherapeutic group: Antibacterials for systemic use, gentamicin.
Farmakoterapevtska skupina: zdravila za sistemsko zdravljenje bakterijskih infekcij, gentamicin.
Single dose of 6.6 mg/kg body weight given intravenously once daily for 3-5 consecutive days.
Enkratni odmerek 6,6 mg/kg telesne mase, ki se daje intravensko enkrat na dan 3-5 zaporednih dni.
Current knowledge suggests that foals, especially neonates, are at a higher risk of gentamicin-induced nephrotoxicity compared to adults.
Glede na trenutno znanje je mogoče sklepati, da pri žrebetih, zlasti novorojenih, obstaja večje tveganje za nefrotoksičnost zaradi gentamicina kot pri odraslih konjih.
It was questioned whether the product is effective for these indications and if the low approved doses may in turn increase resistance rates among equine bacteria towards gentamicin.
Pojavilo se je vprašanje, ali je zdravilo učinkovito pri teh indikacijah in ali bi majhni odobreni odmerki lahko povečali delež konjskih bakterij, ki so odporne proti gentamicinu.
Gentamicin is well known to induce nephrotoxicity even at therapeutic doses.
Znano je, da gentamicin povzroča nefrotoksičnost tudi pri terapevtskih odmerkih.
Use only based on the benefit-risk assessment by the responsible veterinarian.
Zdravilo uporabite samo po oceni razmerja med tveganji in koristmi, ki jo poda odgovorni veterinar.
Use of the product deviating from the instructions given in the SPC increases the risk of nephrotoxicity, and may increase the prevalence of bacteria resistant to gentamicin.
Uporaba zdravila na način, ki odstopa od navodil v povzetku glavnih značilnosti zdravila, poveča tveganje za nefrotoksičnost in lahko poveča razširjenost bakterij, odpornih proti gentamicinu.
The CVMP considered that the lack of data and limited scientific evidence would only support a narrow indication, i.e. “For the treatment of infections of the lower respiratory tract in horses caused by aerobic Gramnegative bacteria susceptible to gentamicin.”
Odbor CVMP je menil, da pomanjkljivi podatki in omejeni znanstveni dokazi podpirajo samo ozko indikacijo, in sicer: „Za zdravljenje okužb spodnjih dihal pri konjih, ki jih povzročajo aerobne gramnegativne bakterije, občutljive za gentamicin.“
Particular caution should be taken when administering gentamicin with other potential nephrotoxic medicinal products (containing e.g. NSAIDs, furosemide, and other aminoglycosides).
Posebna previdnost je potrebna, kadar se gentamicin daje sočasno z drugimi zdravili, ki so lahko nefrotoksična (zdravili, ki vsebujejo na primer nesteroidne protivnetne učinkovine, furosemid in druge aminoglikozide).
4.7 Use during pregnancy, lactation or lay The safety in pregnant horses is unknown.
Uporaba v obdobju brejosti, laktacije ali nesnosti Varnost zdravila za breje kobile ni znana.
Gentamicin does not penetrate intracellularly, or into abscesses.
Gentamicin ne prehaja v celice ali abscese.
Foals, calves, sucklings - the first month of life
Gentamicin žrebeta, teleta, sesni mladičiprvi mesec življenja
This is primarily due to its fast bacteriocidal effect against Gram-negative bacteria, its chemical stability and synergy with beta-lactam antibiotics.
Razlogi za to so predvsem njegovo hitro baktericidno delovanje proti gramnegativnim bakterijam, njegova kemijska stabilnost in sinergija z betalaktamskimi antibiotiki.
Vijenac A. Cesarca 16
Vijenac A. Cesarca 16 31000 Osijek Hrvaška
The CVMP notes that there is no MRL for gentamicin for horses.
Odbor CVMP je upošteval, da za gentamicin za konje ni določena mejna vrednost ostankov.
Two other mechanisms of resistance include ribosomal mutations of the binding site of aminoglycosides, the 30S subunit, and the bacteria decreasing the permeability of aminoglycosides.
Med preostalimi mehanizmi odpornosti so še ribosomske mutacije vezavnega mesta za aminoglikozide in podenoto 30S ter mehanizem, preko katerega bakterije zmanjšajo prepustnost za aminoglikozide.
The Committee therefore concluded that a single dose of 6.6 mg gentamicin/kg bw given intravenously once daily for 3-5 consecutive days would provide an efficacious dose for adult horses, when used according to the SPC.
Odbor je zato zaključil, da bo enkratni odmerek 6,6 mg gentamicina/kg telesne mase, dan intravensko enkrat na dan 3-5 zaporednih dni, zagotovil učinkovit odmerek za odrasle konje, če se bo uporabljal v skladu z navodili v povzetku glavnih značilnosti zdravila.
In one mechanism, gentamicin can interfere with the correct amino acid polymerisation and elongation.
Za prvi mehanizem je značilno, da gentamicin ovira pravilno polimerizacijo in elongacijo aminokislin.
The target animal safety of injectable gentamicin products for horses is considered not proven for use in foals.
Varnost zdravil za injiciranje, ki vsebujejo gentamicin, za ciljno živalsko vrsto konje ni bila dokazana pri uporabi pri žrebetih.
Gentamicin is primarily distributed within extracellular fluids.
Gentamicin se v glavnem porazdeli v zunajcelični tekočini.
No margin of safety has been established under the approved dosing regimen.
Terapevtski indeks pri odobrenem režimu odmerjanja ni bil določen.
The safety in pregnant horses is unknown.
Varnost zdravila za breje kobile ni znana.
The Committee for Medicinal Products for Veterinary Use (CVMP) was requested to harmonise the indication(s) and dosing regimens of the concerned products, taking into account the available data and in particular with regard to target animal safety.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) so zaprosili, naj ob upoštevanju razpoložljivih podatkov, zlasti tistih, povezanih z varnostjo ciljne živalske vrste, uskladi indikacijo (indikacije) in režime odmerjanja za zadevna zdravila.
Calves, foals and piglets at the age of one month
Gentamicin teleta, žrebeta in prašički, stari en mesec
31303 Burgdorf Germany
31303 Burgdorf Nemčija
Therefore, the use of the products in foals is not recommended.
Uporaba zdravil pri žrebetih se zato ne priporoča.
The Committee considered that for any other indications for horses for injectable products contaning gentamicin, applicants/marketing authorisation holders (MAHs) would need to submit appropriate data, following up-to-date requirements.
Odbor je menil, da bi predlagatelji/imetniki dovoljenj za promet z zdravilom za katere koli druge indikacije za zdravila za injiciranje, ki vsebujejo gentamicin, pri konjih morali predložiti ustrezne podatke, skladne z najnovejšimi zahtevami.
• on the basis of the available data, the CVMP considered that the dosage regimen should be amended as described in Annex III;
• odbor CVMP je na podlagi razpoložljivih podatkov menil, da je režim odmerjanja treba spremeniti,
Gentamicin sulphate exerts concentration-dependent bacterial killing characteristics.
Gentamicinijev sulfat uničuje bakterije v odvisnosti od koncentracije.
Another mechanism predominates at low concentrations in which amino acid codons are misread by tRNA and proof-reading is impaired.
Drugi mehanizem prevlada pri nizkih koncentracijah, pri katerih tRNA napačno prebere kodone aminokislin, kontrolno branje pa je ovirano.
Germany CP-Pharma Handelsgesellschaft mbH Ostlandring 13
Nemčija CP-Pharma Handelsgesellschaft mbH Ostlandring 13 31303 Burgdorf Nemčija
Gentamicin is a narrow-spectrum Gram-negative bactericidal antimicrobial, without effects on anaerobe bacteria and mycoplasmas.
Gentamicin je antibiotik ozkega spektra z baktericidnim delovanjem proti gramnegativnim bakterijam, ki nima učinkov na anaerobne bakterije in mikoplazme.
Only one proprietary study in support of the approved dosing regimen for a product included in the scope of this referral was provided.The CVMP considered this study was of limited value to their assessment.
Predložena je bila samo ena lastniška študija v podporo odobrenemu režimu odmerjanja za zdravilo, vključeno v sklop tega postopka.
For the treatment of infections of the lower respiratory tract in horses caused by aerobic Gramnegative bacteria susceptible to gentamicin.
Za zdravljenje okužb spodnjih dihal pri konjih, ki jih povzročajo aerobne gramnegativne bakterije, občutljive za gentamicin.
WITHDRAWAL PERIOD Not authorised for use in horses producing meat or milk for human consumption.
Ni dovoljena uporaba pri konjih v laktaciji, katerih meso ali mleko je namenjeno prehrani ljudi.
Gentamicin is deactivated in the presence of inflammatory debris, low oxygen environments and low pH. Gentamicin is eliminated unchanged by the kidney via glomerular filtration, including 85-95% of the dose.
V nespremenjeni obliki se izloča skozi ledvice z glomerulno filtracijo, pri čemer se izloči od 85-95 % odmerka.
Bovine (calves up to 250 kg), porcine (suckling pigs), equine not intended for human consumption, dogs and cats
govedo (teleta do 250 kg), prašiči (sesni prašiči), konji, ki niso namenjeni za prehrano ljudi, psi in mačke
were justified;
Prilogi III, utemeljena;
31303 Burgdorf,
31303 Burgdorf, Nemčija
Enzymatic modification is the most common type of aminoglycoside resistance.
Najpogostejša vrsta odpornosti proti aminoglikozidom je encimska modifikacija.
Nephrotoxicity is especially a concern in foals.
Zlasti je zaskrbljujoča nefrotoksičnost pri žrebetih.
O-Phosphotransferases (APH) - catalyses ATP-dependent phosphorylation of a hydroxyl group
O-fosfotransferaza (APH) - katalizira fosforilacijo hidroksilne kisline, odvisno od ATP.
Cattle, horses (non-food producing), pigs, dogs and cats
govedo, konji (ki niso namenjeni za proizvodnjo živil), prašiči, psi in mačke
O-Adenyltransferases (ANT) - catalyses ATP-dependent adenylation of hydroxyl group
O-adeniltransferaza (ANT) - katalizira adenilacijo hidroksilne kisline, odvisno od ATP;
N-Acetyltransferases (AAC) - catalyses acetyl CoA-dependent acetylation of an amino group
N-acetiltransferaza (AAC) - katalizira acetilacijo aminoskupine, odvisno od acetilkoencima;
4.2 Indications for use, specifying the target species For the treatment of infections of the lower respiratory tract in horses caused by aerobic Gramnegative bacteria susceptible to gentamicin.
Indikacije za uporabo pri ciljnih živalskih vrstah Za zdravljenje okužb spodnjih dihal pri konjih, ki jih povzročajo aerobne gramnegativne bakterije, občutljive za gentamicin.
Estonia Interchemie werken "De Adelaar" Eesti AS
Estonija Interchemie werken "De Adelaar" Eesti AS Vanapere tee 14, Pringi 74001 Viimsi Harjumaa Estonija
Spain Laboratorios e Industrias IVEN, S.A.
Španija Laboratorios e Industrias IVEN, S.A. Polígono Industrial de Vallecas.
10000 Zagreb
Radnička cesta 48 10000 Zagreb Hrvaška
Spain LABORATORIOS MAYMO, S.A.
Španija LABORATORIOS MAYMO, S.A. Via Augusta, 302
Ozzano Emília Bologna
Via Emilia 285 Ozzano Emília Bologna Italija
As such, no margin of safety has been established in neonatal foals.
Posledično terapevtski indeks pri novorojenih žrebetih ni bil določen.
Nephrotoxicity is the main risk to the target animal from gentamicin that could occur within therapeutic doses.
Glavno tveganje za ciljne živali, povezano z gentamicinom, ki se lahko pojavi pri terapevtskih odmerkih, je nefrotoksičnost.
Cattle, pig, horse declared as not being intended for slaugther for human consumption, cat, dog
govedo, prašiči, konji, ki niso namenjeni za zakol za prehrano ljudi, mačke, psi
Non foodproducing horses, cattle and pigs
konji, ki niso namenjeni za proizvodnjo živil, govedo in prašiči
Gentaject 10% Solution for Injection
Gentaject 10% Solution for Injection konji, ki niso namenjeni za zakol za prehrano ljudi
The dosing regimen must not be exceeded.” The CVMP considered the benefit-risk balance for injectable veterinary medicinal products containing gentamicin for horses negative for use in foals.
Odbor CVMP je menil, da je razmerje med tveganji in koristmi zdravil za injiciranje za uporabo v veterinarski medicini, ki vsebujejo gentamicin in se uporabljajo pri konjih, negativno pri uporabi za žrebeta.
Equine not intended for human consumption, dogs, cats
konji, ki niso namenjeni za prehrano ljudi, psi, mačke
Horses, cattle, dogs and cats
konji, govedo, psi in mačke
The CVMP also considered the benefit-risk balance for injectable veterinary medicinal products containing gentamicin for horses positive when the posology for adult horses (with appropriate warnings and advice on dosing) is changed to: “Single dose of 6.6 mg/kg bw given intravenously once daily for 3-5 consecutive days.
Odbor CVMP je prav tako menil, da je razmerje med tveganji in koristmi zdravil za injiciranje za uporabo v veterinarski medicini, ki vsebujejo gentamicin in se uporabljajo pri konjih, pozitivno, če se odmerjanje za odrasle konje (z ustreznimi opozorili in nasveti za odmerjanje) spremeni, kot sledi:
Horses (non-food producing)
Gentamicin konji (ki niso namenjeni za proizvodnjo živil)
4.1 Target species Horses (non food-producing horses).
Ciljne živalske vrste Konji (ki niso namenjeni za proizvodnjo živil).
Germany Bela-Pharm GmbH & Co. KG Lohner Str. 19
Nemčija Bela-Pharm GmbH & Co.
Horses (non food producing horse).
Konji (ki niso namenjeni za proizvodnjo živil).
Non foodproducing horses, cattle, pigs, dogs and cats
konji, ki niso namenjeni za proizvodnjo živil, govedo, prašiči, psi in mačke
Cattle, pigs, horses, dogs, cats
govedo, prašiči, konji, psi, mačke
Non foodproducing horses, cattle, dogs and cats
konji, ki niso namenjeni za proizvodnjo živil, govedo, psi in mačke
As such, gentamicin has a narrow margin of safety.
Posledično ima gentamicin ozek terapevtski indeks.
Cats, cattle, dogs, horses
mačke, govedo, psi, konji
C/ Luis I s/n.
C/ Luis I s/n. 28031 Madrid Španija
Pigs, cattle, dogs, horses
prašiči, govedo, psi, konji
Horse, foal, cattle, calf, pig, piglet, weaner, dog and cat
konji, žrebeta, govedo, teleta, prašiči, prašički, odstavljenci, psi in mačke
Pigs, cats, cattle, dogs, horses
prašiči, mačke, govedo, psi, konji
Horses, cattle, pigs, dogs and cats
Gentamicin konji, govedo, prašiči, psi in mačke
Iceland Franklin Pharmaceuticals Ltd. Athboy Road
Islandija Franklin Pharmaceuticals Ltd. Athboy Road
Sweden Franklin Pharmaceuticals Ltd. Athboy Road
Švedska Franklin Pharmaceuticals Ltd. Athboy Road
The CVMP considered the benefit-risk balance for injectable veterinary medicinal products containing gentamicin for horses positive for the following indication: “For the treatment of infections of the lower respiratory tract in horses caused by Gram-negative bacteria susceptible to gentamicin.”
Odbor CVMP je menil, da je razmerje med tveganji in koristmi zdravil za injiciranje za uporabo v veterinarski medicini, ki vsebujejo gentamicin in se uporabljajo pri konjih, pozitivno za naslednjo indikacijo:
Spain Franklin Pharmaceuticals Ltd. Athboy Road
Španija Franklin Pharmaceuticals Ltd. Athboy Road
4.5 Special precautions for use
Posebni previdnostni ukrepi
Cattle, horse, swine
Gentamicin govedo, konji, svinje
Dog, cat, pig, piglets, cattle, calves, horses
Gentamicin psi, mačke, prašiči, prašički, govedo, teleta, konji
Cattle, horses, dogs and cats
Gentamicin govedo, konji, psi in mačke
Horses (non food producing horses)
Genta Equine konji (ki niso namenjeni za proizvodnjo živil)
Harjumaa
Jakost
Intramuscular Type I hydrolytic glass vial with butyl stopper and aluminium seal.
Intramuskularno Hidrolitična steklena viala tipa I z butilnim zamaškom zaščitenim z aluminijasto kapico.
Intramuscular Type II hydrolytic glass vial with butyl stopper and aluminium seal
Intramuskularno Hidrolitična steklena viala tipa II z butilnim zamaškom zaščitenim z aluminijasto kapico.